Nov_Home_Banner
Using Novalent For Bethroom

REVOLUTIONARY ANTIMICROBIAL LIKE NO OTHER

Novalent® is a leading US biotechnology engineering firm which has pioneered the development of long-lasting technology to protect against bacteria and viruses.

Novalent® technology is based on a patented, non-toxic monomolecular layer that continuously kills germs for up to 90 days on surfaces and up to 24 hour on human skin after application. Used by leading US firms including PepsiCo, Pilgrims and HanesBrands, Novalent is private equity backed and is headquartered in Greensboro, North Carolina, with sales offices in five locations around the world.

RESEARCH BASED SOLUTIONS

Field trials demonstrate that Novālent® antimicrobial’s mode of action inhibits the growth of bacteria and fungi in healthcare facilities, animal housing, food processing surfaces, and more.

 
Field-Results
90 Days Protection

An alternative approach

Traditional sanitizers stop working once they dry. The moment microorganisms are reintroduced to a clean surface, regrowth begins, and the threat returns.

Novālent antimicrobial offers an alternative way to inhibit bacteria and fungi from returning to your Novalent-treated surfaces.

Nov_Treatment_banner

Physical action, not chemical

Novālent antimicrobial is unique in that it not only destroys bacteria, fungi, and algae, it also prevents them from re-emerging.

Novalent-investor
Rickard Gardell
Founder and Senior Managing Director of Australia’s largest private equity firm, Pacific Equity Partners (A$5 billion AUM).
Investor-2
Simon Pillar
Founder and Senior Managing Director of Australia’s largest private equity firm, Pacific Equity Partners (A$5 billion AUM).
Investor-4
Christer Gardell (Family Office)
Founder and Managing Partner of Europe’s largest activist hedge fund, Cevian Capital (€13 billion AUM).
Investor-3
Sam Zell (Family Office)
Founder and CEO of Equity Residential, a leading American real estate investment trust company ($20 billion market capitalization).
Investor-6
Ron Vela
Former CEO of three of the largest food companies in Australasia, with combined revenues of NZ$3 billion: Goodman Fielder (Baking and Commercial), Tegel and Griffin’s.
Investor-5
Dan Spira
CEO of iNova, leading Asia-Pacific consumer healthcare company (A$400 million revenue).